DANAHER CORP /DE/
DHRNYSE · SIC 3823
$203.83
↓ -0.6%Jul 17 close · end-of-day
Price
1Y↑ +6.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$145.0B
Enterprise Value
$163.4B
P/E
39.3
P/S
5.9
P/B
2.7
EV/EBITDA
29.6
PEG
—
FCF Yield
3.6%
Dividend Yield
—
Revenue (TTM)
$24.8B
Net Income (TTM)
$3.7B
Free Cash Flow (TTM)
$5.3B
Gross Margin
58.9%
Operating Margin
19.2%
Net Margin
14.9%
ROE
7.0%
ROIC
5.6%
Debt / Equity
0.3
Net Cash
-$18.5B
Return 1Y
+5.4%
Company profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics.
- CEO
- Rainer M. Blair
- Sector
- Manufacturing
- Industry
- Measuring And Control Equipment
- Employees
- 81,000
- Headquarters
- District Of Columbia
- Website
- danaher.com
Management & directors
- Bouda ChristopherVP, Chief Accounting Officer
- Couchara GeorgeannSVP, Human Resources
- Blair RainerPresident & CEO
- Gray R BradleySVP Strategic Development
- Gugino Matthew EEVP & Chief Financial Officer
- Gutierrez-Ramos Jose-CarlosSVP, Chief Science Officer
- Leiken JonathanSVP-Chief Legal Officer
- Mcgrew MatthewEVP & Chief Financial Officer
- Milosevich Gregory MExecutive Vice President
- Riley Christopher PaulExecutive Vice President
- Sawyer Montgomery Julie AExecutive Vice President
- Rales Mitchell PChairman of Exec. Committee
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-07-21
DHR Q1 2026 Earnings
Period ends 2026-03-27
MetricActualYoY
Revenue$6.0B↑ +3.7%
Diluted EPS$1.45↑ +9.8%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $22.3B | $24.8B | $26.6B | $23.9B | $23.9B | $24.6B |
| Gross profit | $12.5B | $15.2B | $16.2B | $14.0B | $14.2B | $14.5B |
| Operating income | $4.2B | $6.4B | $7.5B | $5.2B | $4.9B | $4.7B |
| Net income | $3.6B | $6.4B | $7.2B | $4.8B | $3.9B | $3.6B |
| Diluted EPS | $4.89 | $8.61 | $9.66 | $6.38 | $5.29 | $5.05 |
| Operating cash flow | $6.2B | $8.4B | $8.5B | $7.2B | $6.7B | $6.4B |
| Free cash flow | $5.4B | $7.1B | $7.4B | $5.8B | $5.3B | $5.3B |
| Gross margin | 56.0% | 61.4% | 60.8% | 58.7% | 59.5% | 59.1% |
| Operating margin | 19.0% | 25.7% | 28.3% | 21.8% | 20.4% | 19.1% |
| Net margin | 16.4% | 25.9% | 27.1% | 19.9% | 16.3% | 14.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.7B | $5.8B | $6.5B | $5.7B | $5.9B | $6.1B | $6.8B | $6.0B |
| Gross profit | $3.4B | $3.4B | $3.9B | $3.5B | $3.5B | $3.5B | $4.0B | $3.6B |
| Operating income | $1.2B | $958.0M | $1.4B | $1.3B | $760.0M | $1.2B | $1.5B | $1.3B |
| Net income | $907.0M | $818.0M | $1.1B | $954.0M | $555.0M | $908.0M | $1.2B | $1.0B |
| Diluted EPS | $1.22 | $1.12 | $1.50 | $1.32 | $0.77 | $1.27 | $1.69 | $1.45 |
| Operating cash flow | $1.4B | $1.5B | $2.0B | $1.3B | $1.3B | $1.7B | $2.1B | $1.3B |
| Free cash flow | $1.1B | $1.2B | $1.5B | $1.1B | $1.1B | $1.4B | $1.7B | $1.1B |
| Gross margin | 59.7% | 58.7% | 59.5% | 61.2% | 59.3% | 58.2% | 58.0% | 60.3% |
| Operating margin | 20.3% | 16.5% | 21.8% | 22.2% | 12.8% | 19.1% | 22.0% | 22.6% |
| Net margin | 15.8% | 14.1% | 16.6% | 16.6% | 9.3% | 15.0% | 17.5% | 17.3% |
Company news
Jul 20, 2026
Jul 17, 2026
- 2d agoAbbott Just Showed Its Growth Engine Has More Than One Cylindertrefis.com
- 3d agoThe Zacks Analyst Blog Highlights Interactive Brokers, Danaher, S&P Global and Optical Cablefinance.yahoo.com
- 3d agoCan Abbott Stock Deliver on Its Second-Half Growth Promise?trefis.com
- 3d agoDanaher (DHR) Is Expanding Diagnostics With A StatLab Medical Products Dealfinance.yahoo.com
- 3d agoDanaher (DHR) Stock May Trade At A Discount Despite Its 18% Five Year Declinefinance.yahoo.com
- 3d agoCan Masimo’s Integration and Bioprocessing Strength Reshape Danaher’s Long-Term Story (DHR)?finance.yahoo.com
Jul 16, 2026
- 3d agoTop Research Reports for Interactive Brokers, Danaher & S&P Globalfinance.yahoo.com
- 4d agoWill Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?finance.yahoo.com
- 4d agoDanaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?finance.yahoo.com
- 4d agoCountdown to Danaher (DHR) Q2 Earnings: A Look at Estimates Beyond Revenue and EPSfinance.yahoo.com
Jul 15, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Zerhouni Elias A. | Tax withholding | 1,181 | $200.79 | $237,132.99 | filing |
| 2026-07-15 | FILLER LINDA | Tax withholding | 1,181 | $200.79 | $237,132.99 | filing |
| 2026-07-15 | Zerhouni Elias A. | Option exercise | 3,298 | $71.88 | $237,060.24 | filing |
| 2026-07-15 | FILLER LINDA | Option exercise | 3,298 | $71.88 | $237,060.24 | filing |
| 2026-07-15 | Bouda Christopher· VP, Chief Accounting Officer | Tax withholding | 60 | $200.79 | $12,047.40 | filing |
| 2026-05-15 | Couchara Georgeann· SVP, Human Resources | Tax withholding | 281 | $161.91 | $45,496.71 | filing |
| 2026-05-15 | Dewan Feroz | Award | 680 | $0.00 | $0.00 | filing |
| 2026-05-15 | Lamanna Charles W | Award | 680 | $0.00 | $0.00 | filing |
| 2026-05-15 | SPOON ALAN G | Award | 680 | $0.00 | $0.00 | filing |
| 2026-05-15 | FILLER LINDA | Award | 680 | $0.00 | $0.00 | filing |
| 2026-05-15 | Stevens Raymond C | Award | 680 | $0.00 | $0.00 | filing |
| 2026-05-15 | Sanders A Shane | Award | 680 | $0.00 | $0.00 | filing |
| 2026-05-15 | List Teri | Award | 680 | $0.00 | $0.00 | filing |
| 2026-05-15 | Zerhouni Elias A. | Award | 680 | $0.00 | $0.00 | filing |
| 2026-05-01 | SPOON ALAN G | Sale | 1,358 | $174.67 | $237,206.88 | filing |
| 2026-05-01 | SPOON ALAN G | Option exercise | 3,298 | $71.88 | $237,060.24 | filing |
| 2026-03-01 | Riley Christopher Paul· Executive Vice President | Tax withholding | 1,115 | $210.64 | $234,863.60 | filing |
| 2026-03-01 | Sawyer Montgomery Julie A· Executive Vice President | Tax withholding | 1,080 | $210.64 | $227,491.20 | filing |
| 2026-03-01 | Gutierrez-Ramos Jose-Carlos· SVP, Chief Science Officer | Tax withholding | 284 | $210.64 | $59,821.76 | filing |
| 2026-03-01 | Gugino Matthew E· EVP & Chief Financial Officer | Tax withholding | 231 | $210.64 | $48,657.84 | filing |
| 2026-03-01 | Bouda Christopher· VP, Chief Accounting Officer | Tax withholding | 170 | $210.64 | $35,808.80 | filing |
| 2026-03-01 | Milosevich Gregory M· Executive Vice President | Tax withholding | 118 | $210.64 | $24,855.52 | filing |
| 2026-03-01 | Couchara Georgeann· SVP, Human Resources | Tax withholding | 113 | $210.64 | $23,802.32 | filing |
| 2026-03-01 | Gutierrez-Ramos Jose-Carlos· SVP, Chief Science Officer | Award | 6,647 | $0.00 | $0.00 | filing |
| 2026-03-01 | Riley Christopher Paul· Executive Vice President | Award | 6,172 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.